JnJ talc unit faces skepticism on bankruptcy settlement support Ruchika Sharma12 April 2023 2:43 PM ISTUS: A Johnson & Johnson company on Tuesday defended its second attempt to resolve talc lawsuits in bankruptcy, telling a U.S. judge it can...
Johnson and Johnson talc unit 2nd bankruptcy must be dismissed, cancer victims' lawyers say Ruchika Sharma11 April 2023 2:48 PM ISTUS: Johnson & Johnson’s second attempt to resolve talc lawsuits in bankruptcy should be dismissed as an unprecedented fraud designed to deny...
Johnson & Johnson proposes USD 8.9 billion settlement for talc cancer claims Roshni Dhar6 April 2023 3:53 PM ISTUS pharmaceutical giant Johnson & Johnson on Tuesday proposed an $8.9 billion settlement to resolve years-old lawsuits claiming that its talcum...
Health Bulletin 5/April/2023 Roshni Dhar5 April 2023 5:34 PM ISTHere are the top health stories for the day:People need to remain vigilant against new COVID strain: OfficialRajasthan doctors call off strike on RTH...
JnJ proposes USD 8.9 billion settlement of talc cancer claims Ruchika Sharma5 April 2023 4:21 PM ISTThe company said the newly proposed settlement is not "an admission of wrongdoing, nor an indication that the company has changed its longstanding...
JnJ unit loses bid to stay in bankruptcy during Supreme Court appeal Ruchika Sharma1 April 2023 3:35 PM ISTUnited States: A Johnson & Johnson company cannot delay a court order dismissing its bankruptcy, a U.S. court said on Friday, despite the...
Johnson and Johson to discontinue late-stage study of RSV vaccine Ruchika Sharma31 March 2023 4:00 PM ISTPfizer and GSK are running a tight race to tap into the RSV vaccine market, which is estimated to be more than $5 billion and could exceed $10 billion...
Pfizer, Bristol Myers, AbbVie drugs likely to face US price negotiation Ruchika Sharma14 March 2023 3:30 PM ISTNovo Nordisk's diabetes drug Ozempic, prostate cancer treatment Xtandi from Astellas Pharma and Pfizer, and J&J's blood thinner Xarelto are on three...
Bristol Myers Squibb, Janssen launch Phase 3 Librexia clinical trial program evaluating Milvexian Ruchika Sharma5 March 2023 2:30 PM ISTPrinceton: Bristol Myers Squibb in collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson...
Judge indicates intention to dismiss JnJ talc unit bankruptcy Ruchika Sharma15 Feb 2023 3:15 PM ISTLTL's bankruptcy had put the deluge of talc cases on hold.
Johnson & Johnson names Ex-Sanofi Chief Dr John Reed as Executive Vice President, Pharmaceuticals, RnD Ruchika Sharma14 Feb 2023 12:15 PM ISTDr Reed previously served as Executive Vice President, Global Head of Research and Development for Sanofi and brings more than 35 years of biomedical...
JnJ forecasts strong 2023 profit on pharma boost Ruchika Sharma26 Jan 2023 1:00 PM ISTBengaluru: Johnson & Johnson on Tuesday forecast annual profit above Wall Street estimates, as strong demand for its drugs such as cancer...
